Heart Test Laboratories (HSCS) Stock Forecast, Price Target & Predictions
HSCS Stock Forecast
Heart Test Laboratories stock forecast is as follows: an average price target of $3.00 (represents a -21.47% downside from HSCS’s last price of $3.82) and a rating consensus of 'Buy', based on 1 wall street analysts offering a 1-year stock forecast.
HSCS Price Target
The average price target for Heart Test Laboratories (HSCS) is $3.00 based on 1-year price targets from 1 Wall Street analysts in the past 3 months, with a price target range of $3.00 to $3.00. This represents a potential -21.47% downside from HSCS's last price of $3.82.
HSCS Analyst Ratings
According to 1 Wall Street analysts, Heart Test Laboratories's rating consensus is 'Buy'. The analyst rating breakdown for HSCS stock is 0 'Strong Buy' (0.00%), 1 'Buy' (100.00%), 0 'Hold' (0.00%), 0 'Sell' (0.00%), and 0 'Strong Sell' (0.00%).
Heart Test Laboratories Price Target by Analyst
| Date | Analyst | Company | Price Target | Price when Published | Price Target/Price when Published | Price Target/Last Closing Price |
|---|---|---|---|---|---|---|
| Dec 19, 2022 | Maxim Group | $3.00 | $0.90 | 233.33% | -21.47% |
The latest Heart Test Laboratories stock forecast, released on Dec 19, 2022 by Maxim Group company, set a price target of $3.00, which represents a 233.33% increase from the stock price at the time of the forecast ($0.90), and a -21.47% decrease from HSCS last price ($3.82).
Heart Test Laboratories Price Target by Period
| 1M | 3M | 12M | |
|---|---|---|---|
| # Anlaysts | - | - | - |
| Avg Price Target | - | - | - |
| Last Closing Price | $3.82 | $3.82 | $3.82 |
| Upside/Downside | -100.00% | -100.00% | -100.00% |
In the current month, the average price target of Heart Test Laboratories stock is -, according to 0 Wall Street analyst offering twelve months forecast. The average price target represents a -100.00% decrease as opposed to Heart Test Laboratories's last price of $3.82. This month's average price target is down NaN% compared to last quarter, and down NaN% compared to last year.
Analyst Ratings Upgrades/Downgrades
| Date | Company | Previous Rating | New Rating | Rating Change |
|---|---|---|---|---|
| Dec 19, 2022 | Maxim Group | Buy | Buy | Hold |
Heart Test Laboratories's last stock rating was published by Maxim Group on Dec 19, 2022. The company gave HSCS a "Buy" rating, the same as its previous rate.
Heart Test Laboratories Financial Forecast
Heart Test Laboratories Revenue Forecast
| May 26 | Jan 26 | Oct 25 | Jul 25 | May 25 | Jan 25 | Oct 24 | Jul 24 | May 24 | Jan 23 | Jul 22 | |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | - | - | - | - | - | - | - | - | - | $1.95K | $3.20K |
| Avg Forecast | $500.00K | $100.00K | $350.00K | $200.00K | $50.00K | $550.00K | $400.00K | $200.00K | $50.00K | $1.00K | $3.00K |
| High Forecast | $500.00K | $100.00K | $350.00K | $200.00K | $50.00K | $550.00K | $400.00K | $200.00K | $50.00K | $1.00K | $3.00K |
| Low Forecast | $500.00K | $100.00K | $350.00K | $200.00K | $50.00K | $550.00K | $400.00K | $200.00K | $50.00K | $1.00K | $3.00K |
| # Analysts | 1 | 1 | 1 | 1 | 1 | 1 | 2 | 1 | 1 | 1 | 1 |
| Surprise % | - | - | - | - | - | - | - | - | - | 1.95% | 1.07% |
Heart Test Laboratories's average Quarter revenue forecast for May 24 based on 1 analysts is $50.00K, with a low forecast of $50.00K, and a high forecast of $50.00K. HSCS's average Quarter revenue forecast represents a 2464.10% increase compared to the company's last Quarter revenue of $1.95K (Jan 23).
Heart Test Laboratories EBITDA Forecast
| May 26 | Jan 26 | Oct 25 | Jul 25 | May 25 | Jan 25 | Oct 24 | Jul 24 | May 24 | Jan 23 | Jul 22 | |
|---|---|---|---|---|---|---|---|---|---|---|---|
| # Analysts | 1 | 1 | 1 | 1 | 1 | 1 | 2 | 1 | 1 | 1 | 1 |
| EBITDA | - | - | - | - | - | - | - | - | - | $-1.30M | $-1.42M |
| Avg Forecast | $-500.00K | $-100.00K | $-350.00K | $-200.00K | $-50.00K | $-550.00K | $-400.00K | $-200.00K | $-50.00K | $-1.00K | $-3.00K |
| High Forecast | $-500.00K | $-100.00K | $-350.00K | $-200.00K | $-50.00K | $-550.00K | $-400.00K | $-200.00K | $-50.00K | $-1.00K | $-3.00K |
| Low Forecast | $-500.00K | $-100.00K | $-350.00K | $-200.00K | $-50.00K | $-550.00K | $-400.00K | $-200.00K | $-50.00K | $-1.00K | $-3.00K |
| Surprise % | - | - | - | - | - | - | - | - | - | 1302.44% | 474.43% |
undefined analysts predict HSCS's average Quarter EBITDA for undefined to be $NaN, with a high of $NaN and a low of $NaN. This is NaN% lower than Heart Test Laboratories's previous annual EBITDA (undefined) of $NaN.
Heart Test Laboratories Net Income Forecast
| May 26 | Jan 26 | Oct 25 | Jul 25 | May 25 | Jan 25 | Oct 24 | Jul 24 | May 24 | Jan 23 | Jul 22 | |
|---|---|---|---|---|---|---|---|---|---|---|---|
| # Analysts | 1 | 1 | 1 | 1 | 1 | 1 | 2 | 1 | 1 | 1 | 1 |
| Net Income | - | - | - | - | - | - | - | - | - | $-1.37M | $-1.72M |
| Avg Forecast | $-789.00M | $-944.97M | $-1.08B | $-1.36B | $-1.61B | $-1.91B | $-2.14B | $-2.11B | $-3.21B | $-14.68B | $-21.78M |
| High Forecast | $-789.00M | $-944.97M | $-1.08B | $-1.36B | $-1.61B | $-1.91B | $-2.14B | $-2.11B | $-3.21B | $-14.68B | $-21.78M |
| Low Forecast | $-789.00M | $-944.97M | $-1.08B | $-1.36B | $-1.61B | $-1.91B | $-2.14B | $-2.11B | $-3.21B | $-14.68B | $-21.78M |
| Surprise % | - | - | - | - | - | - | - | - | - | 0.00% | 0.08% |
Heart Test Laboratories's average Quarter net income forecast for undefined is $NaN, with a range of $NaN to $NaN. HSCS's average Quarter net income forecast represents a NaN% decrease compared to the company's last Quarter net income of $NaN (undefined).
Heart Test Laboratories SG&A Forecast
| May 26 | Jan 26 | Oct 25 | Jul 25 | May 25 | Jan 25 | Oct 24 | Jul 24 | May 24 | Jan 23 | Jul 22 | |
|---|---|---|---|---|---|---|---|---|---|---|---|
| # Analysts | 1 | 1 | 1 | 1 | 1 | 1 | 2 | 1 | 1 | 1 | 1 |
| SG&A | - | - | - | - | - | - | - | - | - | $667.24K | $997.06K |
| Avg Forecast | $107.59M | $21.52M | $75.32M | $43.04M | $10.76M | $118.35M | $86.08M | $43.04M | $10.76M | $215.19K | $645.57K |
| High Forecast | $107.59M | $21.52M | $75.32M | $43.04M | $10.76M | $118.35M | $86.08M | $43.04M | $10.76M | $215.19K | $645.57K |
| Low Forecast | $107.59M | $21.52M | $75.32M | $43.04M | $10.76M | $118.35M | $86.08M | $43.04M | $10.76M | $215.19K | $645.57K |
| Surprise % | - | - | - | - | - | - | - | - | - | 3.10% | 1.54% |
Heart Test Laboratories's average Quarter SG&A projection for May 24 is $10.76M, based on 1 Wall Street analysts, with a range of $10.76M to $10.76M. The forecast indicates a 1512.55% rise compared to HSCS last annual SG&A of $667.24K (Jan 23).
Heart Test Laboratories EPS Forecast
| May 26 | Jan 26 | Oct 25 | Jul 25 | May 25 | Jan 25 | Oct 24 | Jul 24 | May 24 | Jan 23 | Jul 22 | |
|---|---|---|---|---|---|---|---|---|---|---|---|
| # Analysts | 1 | 1 | 1 | 1 | 1 | 1 | 2 | 1 | 1 | 1 | 1 |
| EPS | - | - | - | - | - | - | - | - | - | $-0.17 | $-0.30 |
| Avg Forecast | $-0.86 | $-1.03 | $-1.18 | $-1.48 | $-1.76 | $-2.08 | $-2.33 | $-2.31 | $-3.50 | $-16.00 | $-28.00 |
| High Forecast | $-0.86 | $-1.03 | $-1.18 | $-1.48 | $-1.76 | $-2.08 | $-2.33 | $-2.31 | $-3.50 | $-16.00 | $-28.00 |
| Low Forecast | $-0.86 | $-1.03 | $-1.18 | $-1.48 | $-1.76 | $-2.08 | $-2.33 | $-2.31 | $-3.50 | $-16.00 | $-28.00 |
| Surprise % | - | - | - | - | - | - | - | - | - | 0.01% | 0.01% |
According to undefined Wall Street analysts, Heart Test Laboratories's projected average Quarter EPS for undefined is $NaN, with a low estimate of $NaN and a high estimate of $NaN. This represents a NaN% decrease compared to HSCS previous annual EPS of $NaN (undefined).